Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial. Rascol O, Cochen de Cock V, Pavy-Le Traon A, Foubert-Samier A, et al. Mov Disord 2021;36:1704-1711.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rascol O, Cochen de Cock V, Pavy-Le Traon A, Foubert-Samier A, et al. Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial. Mov Disord 2021;36:1704-1711.
PMID: 33792958